Community Health Systems Inc is a publicly owned hospital operator in the United States... Show more
Community Health Systems, one of the nation's largest hospital operators, has spent the past several quarters reshaping its portfolio through divestitures while managing cost pressures across its network. This earnings report matters because it reveals whether the company's remaining, same-store facilities can sustain growth as divested hospitals roll off the top line. The third quarter also tested investor assumptions about payer mix, specialist fee inflation, and supplemental reimbursement programs. Coming on the heels of a narrower loss in the second quarter, the latest results offer a fresh read on whether management's back-half recovery expectations are materializing or fading.
For the third quarter ended September 30, 2026, Community Health Systems reported a net loss attributable to stockholders of $86 million, or $0.63 per share, compared with net income of $130 million, or $0.96 per share, in the prior-year period. Excluding specified adjusting items, the company posted an adjusted loss of $0.48 per share, versus earnings of $1.27 per share a year earlier. That adjusted figure fell short of the consensus estimate of roughly a $0.29 loss.
Net operating revenues declined 10.7% to $2.76 billion from $3.09 billion, missing the approximately $2.80 billion consensus forecast. The decline primarily reflected hospital divestitures, though same-store revenue increased 3.8%, supported by a 2.2% rise in same-store admissions and 3.6% growth in adjusted admissions. Adjusted EBITDA fell 25.5% to $280 million from $376 million, as unfavorable payer mix, lower non-patient revenue, and higher medical specialist fees and supplemental reimbursement program expenses weighed on results.
Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors monitoring healthcare names like Community Health Systems, it offers a streamlined way to surface comparable opportunities and signals. Consider exploring the AI Screener to support your own research process.
The market responded negatively to the results, with shares falling roughly 12% in after-hours trading following the release. The miss on both revenue and adjusted EPS, combined with a downward revision to full-year guidance, appeared to outweigh the more encouraging same-store trends. Investor sentiment had already been cautious heading into the report, reflecting concerns about divestiture-driven revenue declines, lingering payer-mix headwinds, and the sustainability of cost-control efforts. The guidance cut reinforced those worries by signaling that management expects weaker profitability through the remainder of the fiscal year.
Community Health Systems lowered its 2026 guidance, now projecting net operating revenues of $11.3 billion to $11.5 billion, adjusted EBITDA of $1.225 billion to $1.275 billion, and a net loss per share of $1.60 to $1.70. The prior outlook had called for revenue of $11.40 billion to $11.60 billion, adjusted EBITDA of $1.300 billion to $1.375 billion, and a loss per share of $1.10 to $1.25.
Investors should watch several factors in the quarters ahead. First, the trajectory of same-store volumes will be important, since underlying admissions and adjusted admissions continued to grow even as divestitures reduced reported revenue. Second, payer mix remains a key swing factor, as unfavorable shifts toward lower-reimbursement coverage have pressured margins.
Third, specialist fee inflation and supplemental reimbursement program costs bear close monitoring, given their direct impact on adjusted EBITDA. Finally, the company's ongoing portfolio reshaping, including any further divestitures or debt-reduction moves, could influence both the top line and balance-sheet health. Management's commentary on the upcoming conference call may offer additional color on whether the same-store recovery can offset these structural headwinds.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
an operator of general acute care hospitals
Industry HospitalNursingManagement